Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Valuing ResApp Health, page-272

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 272 Last

Share
Profile

Follow
pilko3

6,856 Posts.

885

29/05/22

21:39

Post #: 61691217
Share

Originally posted by Phantom1: ↑

Portsmouth, that is “the rub” so to speak.

We do not have an idea if the COVID test distinguishes between viral diseases (eg RSV, influenza, COVID). These specific viruses are not specified in the ResApp Dx. This needs to be done IMO for the test to be at all worthwhile (and accepted from a regulatory point of view). Otherwise it is a test for a “viral respiratory disease” versus “non viral resp disease” or, even less usefully, normal. While interesting, and the result could be clinically useful, the whole point is to have an app for COVID surveillance, not for viral respiratory
Infections as a group I would think.

Further work is needed by the company. I
believe the potential COVID app is oversold as a product but I am certainly very happy to be proven wrong and hope all holders make a killing.

If I am wrong it is certainly worth a lot of money. Too risky for me though.

Expand

Oh go on take a little punt...its only money and money is not worth the paper it is printed on...lol. Only kidding...it makes the world go bad...I mean round.

RAP Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

IRE

Iress runs 'hot' for Wealth Within's stock tips

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Failure to report prompts ASX to impose multiple company suspensions

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

There are more pages in this discussion • 195 more messages in this thread...

First 272 Last

Add RAP (ASX) to my watchlist

SPONSORED BY